COX 2-selective NSAIDs: Biology, promises, and concerns

Brian F. Mandell, MD, PhD
Education program director, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Brian F. Mandell, MD, PhD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; mandelb@ccf.org

Dr. Mandell has received personal honoraria, support for educational programs, or research support from Amgen, Ciba-Geigy (Novartis), Merck, Searle, Smith Kline Beecham, and Wyeth Pharmaceuticals.

Brian F. Mandell, MD, PhD
Education program director, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Brian F. Mandell, MD, PhD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; mandelb@ccf.org

Dr. Mandell has received personal honoraria, support for educational programs, or research support from Amgen, Ciba-Geigy (Novartis), Merck, Searle, Smith Kline Beecham, and Wyeth Pharmaceuticals.

Brian F. Mandell, MD, PhD
Education program director, Department of Rheumatic and Immunologic Diseases, Cleveland Clinic

Address: Brian F. Mandell, MD, PhD, Department of Rheumatic and Immunologic Diseases, A50, Cleveland Clinic, 9500 Euclid Avenue, Cleveland, OH 44195; mandelb@ccf.org

Dr. Mandell has received personal honoraria, support for educational programs, or research support from Amgen, Ciba-Geigy (Novartis), Merck, Searle, Smith Kline Beecham, and Wyeth Pharmaceuticals.